Combined HDAC and BET inhibition enhances melanoma vaccine immunogenicity and efficacy
The combined inhibition of histone deacetylases (HDAC) and the proteins of the bromodomain and extraterminal (BET) family have recently shown therapeutic efficacy against melanoma, pancreatic ductal adenocarcinoma, testicular, and lymphoma cancers in murine studies. However, in such studies, the rol...
Main Authors: | Badamchi-Zadeh, A, Moynihan, K, Larocca, R, Aid, M, Provine, N, Iampietro, M, Kinnear, E, Penaloza-Macmaster, P, Abbink, P, Blass, E, Tregoning, J, Irvine, D, Barouch, D |
---|---|
Format: | Journal article |
Language: | English |
Published: |
American Association of Immunologists
2018
|
Similar Items
-
Combined HDAC and BET Inhibition Enhances Melanoma Vaccine Immunogenicity and Efficacy
by: Badamchi-Zadeh, Alexander, et al.
Published: (2020) -
Adenovirus serotype 5 vaccine vectors trigger IL-27-dependent inhibitory CD4(+) T cell responses that impair CD8(+) T cell function
by: Larocca, R, et al.
Published: (2016) -
Immunogenicity and cross-reactivity of rhesus adenoviral vectors
by: Iampietro, M, et al.
Published: (2018) -
Immediate dysfunction of vaccine-elicited CD8+ T cells primed in the absence of CD4+ T cells
by: Provine, N, et al.
Published: (2016) -
Inhibitory receptor expression on memory CD8 T cells following Ad vector immunization
by: Penaloza-MacMaster, P, et al.
Published: (2016)